Volume 23, Number 8—August 2017
Dispatch
Risk for Death among Children with Pneumonia, Afghanistan
Table 2
Risk factors for death from pneumonia among children <5 years of age hospitalized at Abu Ali Sina Balkhi Regional Hospital, Mazar-e-Sharif, Afghanistan, December 2012–March 2013
Variable | Discharged, no. (%), n = 542 | Deceased, no. (%), n = 75 | Odds ratio (95% CI) | p value | Adjusted odds ratio (95% CI)* | p value |
---|---|---|---|---|---|---|
Sex | ||||||
F | 186 (34.3) | 32 (42.7) | 1.42 (0.87–2.32) | 0.15 | 1.61 (0.96–2.71) | 0.06 |
M |
356 (65.7) |
43 (57.3) |
1 |
1 |
||
Age, mo | ||||||
<1 (newborn) | 9 (1.7) | 8 (10.7) | 11.1 (3.36–36.6) | <0.01 | 13.1 (3.71–46.5) | <0.01 |
1–11 | 433 (89.9) | 59 (78.6) | 1.70 (0.78–3.67) | 0.17 | 1.59 (0.72–3.49) | 0.24 |
>12 |
100 (18.4) |
8 (10.7) |
1 |
|||
Maternal illiteracy | ||||||
Literate | 83 (15.3) | 7 (9.3) | 0.56 (0.25–1.28) | 0.17 | 0.62 (0.26–1.45) | 0.27 |
Illiterate |
459 (84.7) |
68 (90.7) |
1 |
|||
Duration of illness, d | ||||||
>7 | 80 (14.8) | 17 (22.7) | 1.56 (0.85–2.85) | 0.14 | 1.73 (0.92–3.25) | 0.08 |
<7 |
462 (85.2) |
58 (77.3) |
1 |
|||
Ethnicity | ||||||
Tajik | 252 (46.5) | 35 (46.7) | 1 | |||
Pashtoon | 105 (19.4) | 16 (21.3) | 1.09 (0.58–2.06) | 0.77 | 0.80 (0.40–1.60) | 0.54 |
Uzbek | 62 (11.5) | 10 (13.3) | 1.16 (0.54–2.47) | 0.69 | 1.04 (0.47–2.31) | 0.91 |
Hazara | 89 (16.4) | 11 (14.7) | 0.88 (0.43–1.82) | 0.75 | 0.81 (0.38–1.72) | 0.58 |
Other |
34 (6.3) |
3 (4.0) |
0.63 (0.18–2.17) |
0.47 |
0.48 (0.13–1.75) |
0.27 |
Received antimicrobial drugs before hospitalization | ||||||
Yes | 476 (87.8) | 65 (86.7) | 1.09 (0.47–2.49) | 0.83 | ||
No | 56 (10.3) | 7 (9.3) | 1 | |||
Unknown |
10 (1.9) |
3 (4.0) |
2.4 (0.52–10.9) |
0.24 |
||
Bacillus Calmette–Guérin vaccine | ||||||
Received | 474 (87.4) | 55 (73.3) | 0.39 (0.22–0.69) | <0.01 | 0.47 (0.25–0.88) | 0.02 |
Not received |
68 (12.6) |
20 (26.7) |
1 |
|||
>1 dose pentavalent vaccine, n = 547† | ||||||
Received | 380 (79.0) | 44 (66.7) | 0.53 (0.30–0.92) | 0.02 | ||
Not received |
101 (21.0) |
22 (33.3) |
1 |
|||
Measles vaccine, n = 165† | ||||||
Received | 98 (64.9) | 6 (42.9) | 0.40 (0.13–1.23) | 0.11 | ||
Not received |
53 (35.1) |
8 (57.1) |
1 |
|||
Vitamin A, n = 336† | ||||||
Received | 111 (37.1) | 7 (18.9) | 0.39 (0.16–0.92) | 0.03 | ||
Not received |
188 (62.9) |
30 (81.1) |
1 |
|||
Malnutrition‡ | ||||||
Detected | 199 (36.7) | 41 (54.7) | 2.06 (1.26–3.35) | <0.01 | 2.06 (1.22–3.49) | <0.01 |
Not detected |
340 (62.7) |
34 (45.3) |
1 |
|||
Anemia | ||||||
Detected | 246 (45.4) | 39 (52.0) | 1.32 (0.76–2.29) | 0.31 | ||
Not detected | 192 (35.4) | 23 (30.7) | 1 | |||
Not evaluated | 104 (19.2) | 13 (17.3) | 1.04 (0.50–2.14) | 0.90 |
*Age, sex, ethnicities and variables with p<0.2 in univariate analyses were included in multivariate analysis; blank cells indicate variables without p<0.2 in univariate analysis. Because they had collinearity, bacillus Calmette–Guérin vaccine was included with vaccines and vitamin A was included in multivariate analysis.
†No. children eligible for the vaccines or vitamin A.
‡3 children, whose nutritional status was unknown, were excluded.
1These authors contributed equally to this article.